Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
Nippon India Pharma Fund(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Limited13.430262563491085.2889
Domestic EquitiesDivi's Laboratories Limited9.28261298808750.1201
Domestic EquitiesLupin Limited7.27302898126587.7255
Domestic EquitiesCipla Limited5.71103200000461.5040
Domestic EquitiesApollo Hospitals Enterprise Limited5.3119648795429.2557
Domestic EquitiesDr. Reddy's Laboratories Limited5.18533662170419.0255
Domestic EquitiesGlaxoSmithKline Pharmaceuticals Limited3.60691011921291.4687
Domestic EquitiesVijaya Diagnostic Centre Limited3.52922831564285.1951
Domestic EquitiesAbbott India Limited3.456990933279.3512
Domestic EquitiesMedPlus Health Services Limited3.41143627277275.6731
Domestic EquitiesAjanta Pharma Limited3.1139959323251.6304
Domestic EquitiesGland Pharma Limited3.01371529352243.5340
Domestic EquitiesNarayana Hrudayalaya Limited2.98621426170241.3151
Domestic EquitiesAurobindo Pharma Limited2.44511702630197.5902
Domestic EquitiesZydus Lifesciences Limited2.19452000632177.3360
Domestic EquitiesDr. Lal Path Labs Limited2.1752709112175.7747
Domestic EquitiesTorrent Pharmaceuticals Limited2.0107503364162.4834
Domestic EquitiesJB Chemicals & Pharmaceuticals Limited2.0080999649162.2630
Domestic EquitiesAlkem Laboratories Limited1.9553323678158.0099
Domestic EquitiesMankind Pharma Limited1.9475649036157.3750
Domestic EquitiesSanofi India Limited1.6315230272131.8399
Domestic EquitiesPfizer Limited1.5771318249127.4428
Domestic EquitiesThyrocare Technologies Limited1.48521765838120.0152
Domestic EquitiesIPCA Laboratories Limited1.4597785412117.9610
Domestic EquitiesSai Life Sciences Limited1.34681430423108.8337
Domestic EquitiesSanofi Consumer Healthcare India Limited1.2762213659103.1279
Domestic EquitiesSuraksha Diagnostic Limited1.0167316961882.1565
Domestic EquitiesSyngene International Limited1.0108112479581.6826
Domestic EquitiesBiocon Limited0.9659228422278.0519
Domestic EquitiesFortis Healthcare Limited0.9540110388977.0901
Domestic EquitiesAstraZeneca Pharma India Limited0.68256407855.1561
Domestic EquitiesIndoco Remedies Limited0.5288183492442.7335
Domestic EquitiesOrchid Pharma Limited0.473249272738.2405
Domestic EquitiesEmcure Pharmaceuticals Limited0.400630184132.3694
Domestic EquitiesKrishna Institute Of Medical Sciences Limited0.365546178529.5358
Domestic EquitiesConcord Biotech Limited0.232411173818.7787
Total 99.4551 8036.9351
Cash & Cash Equivalents and Net AssetsTriparty Repo0.6989 56.4812
Cash & Cash Equivalents and Net AssetsCash Margin - CCIL0.0004 0.0340
Cash & Cash Equivalents and Net AssetsNet Current Assets-0.1544 -12.4804
Total 0.5449 44.0348
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.